SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGTNewsfile Corp • 09/01/22
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 08/12/22
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 08/11/22
Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Fulgent Genetics, Inc. (FLGT)Business Wire • 08/10/22
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 08/10/22
ONGOING INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 08/09/22
FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 08/09/22
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of InvestorsBusiness Wire • 08/08/22
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of InvestorsBusiness Wire • 08/05/22
The Law Offices of Frank R. Cruz Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of InvestorsBusiness Wire • 08/05/22
Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/05/22
Fulgent Genetics, Inc. (FLGT) Q2 Earnings and Revenues Beat EstimatesZacks Investment Research • 08/05/22
Fulgent Genetics Welcomes Dr. Michael Nohaile and Dr. Leonard Post to Board of DirectorsBusiness Wire • 08/04/22
Fulgent Genetics to Announce Second Quarter 2022 Financial Results on Thursday, August 4, 2022Business Wire • 07/19/22
The American Medical Association Approves a New Category I CPT® Code for the HelioLiver™ TestPRNewsWire • 07/05/22
Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/03/22
Fulgent Genetics, Inc. (FLGT) Surpasses Q1 Earnings and Revenue EstimatesZacks Investment Research • 05/03/22
Fulgent Genetics Announces Opening of New State-of-the-Art Oncology Laboratory in El Monte, CaliforniaBusiness Wire • 05/03/22